Transplant Genomics Inc.

Active Brookline, MA

Transplant Genomics Inc. Overview

Transplant Genomics Inc. filed as a Statement & Designation By Foreign Corporation in the State of California on Tuesday, December 9, 2014 and is approximately ten years old, according to public records filed with California Secretary of State. A corporate filing is called a foreign filing when an existing corporate entity files in a state other than the state they originally filed in. This does not necessarily mean that they are from outside the United States.

Sponsored

Learn More D&B Reports Available for Transplant Genomics Inc.

Network Visualizer

Name
Brian Tees 6 ~ Background Report ~	Chairman
Nicholas Grund ~ Background Report ~	President Director
Dan Dickinson 45 ~ Background Report ~	Director Secretary
Matthew B. Urbanek 13 ~ Background Report ~	Executive Director Vice President Treasurer
David Morgan 6 ~ Background Report ~	President Chairman Director
Justin Dudas 59 ~ Background Report ~	Director Tax Director
Stanely Rose ~ Background Report ~	President
Stanley D. Rose ~ Background Report ~	President Director
Annemarie Watson 7 ~ Background Report ~	Director
Michael Abecassis ~ Background Report ~	Director
Chris O'Connor ~ Background Report ~	Director
Jay Venkatesan ~ Background Report ~	Director

Showing 8 records out of 12

175 Crossing Blvd Framingham, MA 01702 1501 Beacon St Brookline, MA 02446 905 S Main St Mansfield, MA 02048 10 Crestview Ave Medway, MA 02053

California Secretary of State

Filing Type:	Statement & Designation By Foreign Corporation
Status:	Active
State:	California
Foreign State:	Delaware
State ID:	03732466
Date Filed:	Tuesday, December 9, 2014

Texas Secretary of State

Filing Type:	Foreign For-Profit Corporation
Status:	Active In existence
State:	Texas
State ID:	803464534
Date Filed:	Wednesday, November 6, 2019

Florida Department of State

Filing Type:	Foreign for Profit Corporation
Status:	Active
State:	Florida
State ID:	F20000004761
Date Filed:	Tuesday, October 27, 2020

Corporate Notes

Source	Date	Type	Note
	11/6/2019	Application for Registration
	12/31/2020	Public Information Report (PIR)
	8/20/2021	Tax Forfeiture
	8/24/2021	Reversal of Tax Forfeiture
	12/31/2021	Public Information Report (PIR)
	12/31/2022	Public Information Report (PIR)
	12/31/2022	Public Information Report (PIR)

Trademarks for Transplant Genomics Inc.

	Transplant Genomics Serial Number: 86399132 Drawing Code: 5000
	Tgi Serial Number: 86399127 Drawing Code: 4000
	Trugraf Serial Number: 86539762 Drawing Code: 4000
	Transplant Genomics Serial Number: 86399145 Drawing Code: 4000